Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis
BackgroundSuperior outcomes after surgical treatment over medical treatment for primary aldosteronism (PA) has been reported in small-scale clinical studies, but no solid conclusion has been drawn as results of large randomized trials are lacking.MethodsWe performed a search of PubMed, MEDLINE, Emba...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.644260/full |
id |
doaj-2de75e805e8540f89553f34762c2071a |
---|---|
record_format |
Article |
spelling |
doaj-2de75e805e8540f89553f34762c2071a2021-05-17T06:22:25ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-05-011210.3389/fendo.2021.644260644260Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-AnalysisWei-Chieh Huang0Wei-Chieh Huang1Ying-Ying Chen2Ying-Ying Chen3Yen-Hung Lin4Yen-Hung Lin5Jeff S. Chueh6Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, TaiwanSchool of Medicine, National Yang-Ming Chiao-Tung University, Taipei, TaiwanDivision of Nephrology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, TaiwanGraduate Institute of Clinical Medicine, College of Medicine, National Taiwan University Hospital, Taipei, TaiwanGraduate Institute of Clinical Medicine, College of Medicine, National Taiwan University Hospital, Taipei, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanGlickman Urological and Kidney Institute, and Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, United StatesBackgroundSuperior outcomes after surgical treatment over medical treatment for primary aldosteronism (PA) has been reported in small-scale clinical studies, but no solid conclusion has been drawn as results of large randomized trials are lacking.MethodsWe performed a search of PubMed, MEDLINE, Embase and Cochrane Library for randomized or observational studies that investigated cardiovascular outcomes in patients with PA undergoing medical versus surgical treatment. Meta-analyses of both composite and individual outcomes were conducted. Risks of bias of the included studies were assessed with Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) checklist. Trial sequential analysis (TSA) was performed to control the risk of random errors and assess whether the results in our meta-analysis were conclusive.ResultsA total of 12 studies, including a total of 6148 PA patients, were included in the meta-analysis. The results of meta-analyses demonstrated lower incidence of composite cardiovascular outcomes among PA patients who underwent surgical treatment over medical treatment (odds ratio (OR): 0.49). Surgical treatment also led to less incidence of persistence of hypertension (OR of non-cure hypertension: 0.31). Fewer major cardiovascular events and mortality events were observed (OR: 0.60) after surgical treatment. TSA result showed that the required information size was 2151 and the cumulative Z curve crossed the futility boundary and reached the required information size.ConclusionSuperior performance of surgical treatment over medical treatment is confirmed with meta-analyses in terms of lower incidences of composite cardiovascular outcomes and non-cure of hypertension. Hence, adrenalectomy could now be concluded as the treatment of choice for lateralized PA.https://www.frontiersin.org/articles/10.3389/fendo.2021.644260/fullprimary aldosteronismadrenalectomymineralocorticoid receptor antagonistssurgical treatmentmedical treatmentROBINS-I |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Wei-Chieh Huang Wei-Chieh Huang Ying-Ying Chen Ying-Ying Chen Yen-Hung Lin Yen-Hung Lin Jeff S. Chueh |
spellingShingle |
Wei-Chieh Huang Wei-Chieh Huang Ying-Ying Chen Ying-Ying Chen Yen-Hung Lin Yen-Hung Lin Jeff S. Chueh Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis Frontiers in Endocrinology primary aldosteronism adrenalectomy mineralocorticoid receptor antagonists surgical treatment medical treatment ROBINS-I |
author_facet |
Wei-Chieh Huang Wei-Chieh Huang Ying-Ying Chen Ying-Ying Chen Yen-Hung Lin Yen-Hung Lin Jeff S. Chueh |
author_sort |
Wei-Chieh Huang |
title |
Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis |
title_short |
Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis |
title_full |
Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis |
title_fullStr |
Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis |
title_full_unstemmed |
Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis |
title_sort |
composite cardiovascular outcomes in patients with primary aldosteronism undergoing medical versus surgical treatment: a meta-analysis |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Endocrinology |
issn |
1664-2392 |
publishDate |
2021-05-01 |
description |
BackgroundSuperior outcomes after surgical treatment over medical treatment for primary aldosteronism (PA) has been reported in small-scale clinical studies, but no solid conclusion has been drawn as results of large randomized trials are lacking.MethodsWe performed a search of PubMed, MEDLINE, Embase and Cochrane Library for randomized or observational studies that investigated cardiovascular outcomes in patients with PA undergoing medical versus surgical treatment. Meta-analyses of both composite and individual outcomes were conducted. Risks of bias of the included studies were assessed with Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) checklist. Trial sequential analysis (TSA) was performed to control the risk of random errors and assess whether the results in our meta-analysis were conclusive.ResultsA total of 12 studies, including a total of 6148 PA patients, were included in the meta-analysis. The results of meta-analyses demonstrated lower incidence of composite cardiovascular outcomes among PA patients who underwent surgical treatment over medical treatment (odds ratio (OR): 0.49). Surgical treatment also led to less incidence of persistence of hypertension (OR of non-cure hypertension: 0.31). Fewer major cardiovascular events and mortality events were observed (OR: 0.60) after surgical treatment. TSA result showed that the required information size was 2151 and the cumulative Z curve crossed the futility boundary and reached the required information size.ConclusionSuperior performance of surgical treatment over medical treatment is confirmed with meta-analyses in terms of lower incidences of composite cardiovascular outcomes and non-cure of hypertension. Hence, adrenalectomy could now be concluded as the treatment of choice for lateralized PA. |
topic |
primary aldosteronism adrenalectomy mineralocorticoid receptor antagonists surgical treatment medical treatment ROBINS-I |
url |
https://www.frontiersin.org/articles/10.3389/fendo.2021.644260/full |
work_keys_str_mv |
AT weichiehhuang compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis AT weichiehhuang compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis AT yingyingchen compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis AT yingyingchen compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis AT yenhunglin compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis AT yenhunglin compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis AT jeffschueh compositecardiovascularoutcomesinpatientswithprimaryaldosteronismundergoingmedicalversussurgicaltreatmentametaanalysis |
_version_ |
1721438629675401216 |